Immunovant, Inc. IMVT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s total current assets?
- Immunovant, Inc. (IMVT) reported total current assets of $948.82M in Q1 2026.
- How has Immunovant, Inc.'s total current assets changed year-over-year?
- Immunovant, Inc.'s total current assets increased by 23.6% year-over-year, from $767.66M to $948.82M.
- What is the long-term trend for Immunovant, Inc.'s total current assets?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s total current assets has grown at a 18.3% compound annual growth rate (CAGR), from $409.01M to $948.82M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.